AU2001288460A1 - Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant - Google Patents
Compositions for treating sexual dysfunction, containing an no-donor and an antioxidantInfo
- Publication number
- AU2001288460A1 AU2001288460A1 AU2001288460A AU8846001A AU2001288460A1 AU 2001288460 A1 AU2001288460 A1 AU 2001288460A1 AU 2001288460 A AU2001288460 A AU 2001288460A AU 8846001 A AU8846001 A AU 8846001A AU 2001288460 A1 AU2001288460 A1 AU 2001288460A1
- Authority
- AU
- Australia
- Prior art keywords
- antioxidant
- donor
- compositions
- sexual dysfunction
- treating sexual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
Methods for treating sexual dysfunction are disclosed. The methods generally comprise the administration of an NO donor and an antioxidant; the active ingredients can be administered topically to the genitals of the patient. The methods allow for localized NO delivery through topical application of the present compounds, while minimizing, if not preventing, damage associated with peroxynitrite formation. Compositions comprising L-arginine, or a derivative thereof and an antioxidant in a pharmaceutical carrier suitable for application to the genitals is also disclosed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/653,794 US7128930B1 (en) | 2000-09-01 | 2000-09-01 | Compositions and methods for treating sexual dysfunction |
US09/653,794 | 2000-09-01 | ||
PCT/US2001/026817 WO2002019999A2 (en) | 2000-09-01 | 2001-08-29 | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001288460A1 true AU2001288460A1 (en) | 2002-03-22 |
Family
ID=24622335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001288460A Abandoned AU2001288460A1 (en) | 2000-09-01 | 2001-08-29 | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
Country Status (10)
Country | Link |
---|---|
US (1) | US7128930B1 (en) |
EP (1) | EP1317309B1 (en) |
JP (1) | JP2004511443A (en) |
AT (1) | ATE299740T1 (en) |
AU (1) | AU2001288460A1 (en) |
CA (1) | CA2419404C (en) |
DE (1) | DE60112102T2 (en) |
ES (1) | ES2242768T3 (en) |
MX (1) | MXPA03001798A (en) |
WO (1) | WO2002019999A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1022860C2 (en) * | 2003-03-06 | 2004-09-07 | Concepto Worldwide Ltd | Device for stimulating the female sexual organ, packaging and dosing device. |
EP1754478B1 (en) * | 2005-08-04 | 2008-12-31 | Extarma AG | Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function |
US20090197892A1 (en) * | 2007-08-21 | 2009-08-06 | Nawaz Ahmad | Anhydrous compositions useful for attaining enhanced sexual wellness |
US20130210867A1 (en) * | 2010-04-15 | 2013-08-15 | Life Science Enhancement Corporation | Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction |
JP2013049670A (en) * | 2011-08-04 | 2013-03-14 | Fancl Corp | Ascorbic acid preparation |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
DE102013018565A1 (en) | 2013-10-28 | 2015-04-30 | Gmbu E.V., Fachsektion Dresden | Personal care products and their use |
ITMI20132049A1 (en) | 2013-12-09 | 2015-06-10 | Multichem S A S Di Gabriele Segall A | COMPOSITIONS AND METHODS FOR THE STIMULATION OF THE FEMALE AND MALE SEXUAL RESPONSE |
WO2018094377A1 (en) * | 2016-11-21 | 2018-05-24 | REV Pharmaceuticals LLC | Sexual health enhancement composition |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242391A (en) | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
GB9214247D0 (en) | 1992-07-04 | 1992-08-19 | Stephan Peter M | Composition for use as a food or food supplement |
JP3204510B2 (en) | 1993-04-05 | 2001-09-04 | コンペティティブ テクノロジーズ,インク. | Diagnosis and treatment of erectile dysfunction |
US5439938A (en) | 1993-04-07 | 1995-08-08 | The Johns Hopkins University | Treatments for male sexual dysfunction |
ES2091724B1 (en) | 1995-04-07 | 1997-06-01 | Ropero Wermenlinger Luis | NEW POTENTIATING LOTION OF SEXUAL CAPACITY IN MAN, PROCEDURE FOR ITS PREPARATION AND ITS APPLICATIONS. |
US5595753A (en) * | 1995-04-14 | 1997-01-21 | President And Fellows Of Harvard College | Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract |
US5645839A (en) * | 1995-06-07 | 1997-07-08 | Trustees Of Boston University | Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis |
US6207713B1 (en) * | 1997-09-17 | 2001-03-27 | Eric T. Fossel | Topical and oral delivery of arginine to cause beneficial effects |
US6071272A (en) | 1997-10-28 | 2000-06-06 | Hoffman; Alan S. | Method for treating erectile dysfunctionality |
US6180133B1 (en) * | 1997-11-25 | 2001-01-30 | Watson Pharmaceuticals, Inc. | Antioxidant composition for topical/transdermal prevention and treatment of wrinkles |
AU3221599A (en) | 1998-04-03 | 1999-10-25 | Daily Wellness Company, The | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
US6031002A (en) * | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
AU4699299A (en) | 1998-06-26 | 2000-01-17 | Nutracorp Scientific, Inc. | Promoting nitric oxide and cyclic gmp activity |
US6007824A (en) * | 1998-07-09 | 1999-12-28 | Duckett; Melvin J. | Natural composition and method for the treatment of sexual dysfunction |
US6476037B1 (en) * | 2000-03-23 | 2002-11-05 | The Regents Of The University Of California | L-arginine and phosphodiesterase (PDE) inhibitor synergism |
RU2163805C1 (en) | 2000-03-29 | 2001-03-10 | Закрытое Акционерное Общество Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод" | Agent for treatment of men with sexual dysfunction |
-
2000
- 2000-09-01 US US09/653,794 patent/US7128930B1/en not_active Expired - Fee Related
-
2001
- 2001-08-29 DE DE60112102T patent/DE60112102T2/en not_active Expired - Lifetime
- 2001-08-29 WO PCT/US2001/026817 patent/WO2002019999A2/en active IP Right Grant
- 2001-08-29 JP JP2002524484A patent/JP2004511443A/en not_active Withdrawn
- 2001-08-29 AU AU2001288460A patent/AU2001288460A1/en not_active Abandoned
- 2001-08-29 MX MXPA03001798A patent/MXPA03001798A/en active IP Right Grant
- 2001-08-29 EP EP01968197A patent/EP1317309B1/en not_active Expired - Lifetime
- 2001-08-29 CA CA2419404A patent/CA2419404C/en not_active Expired - Fee Related
- 2001-08-29 AT AT01968197T patent/ATE299740T1/en not_active IP Right Cessation
- 2001-08-29 ES ES01968197T patent/ES2242768T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60112102T2 (en) | 2006-05-24 |
WO2002019999A3 (en) | 2003-03-27 |
EP1317309A2 (en) | 2003-06-11 |
DE60112102D1 (en) | 2005-08-25 |
ES2242768T3 (en) | 2005-11-16 |
EP1317309B1 (en) | 2005-07-20 |
MXPA03001798A (en) | 2004-11-01 |
CA2419404C (en) | 2012-10-16 |
ATE299740T1 (en) | 2005-08-15 |
JP2004511443A (en) | 2004-04-15 |
US7128930B1 (en) | 2006-10-31 |
CA2419404A1 (en) | 2002-03-14 |
WO2002019999A2 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001288460A1 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
EP1283054A4 (en) | Drugs for complications of diabetes and neuropathy and utilization thereof | |
CO5271759A1 (en) | FORMULATION IN SOLUTION CONTAINING A MIXTURE OF SOLVENTS | |
ATE197249T1 (en) | STABLE MEDICINAL PRODUCT CONTAINING OXALIPLATIN | |
WO2002017881A3 (en) | Transdermal pharmaceutical delivery composition | |
BR0313575C1 (en) | Method for improving the efficacy and / or transdermal transport of topically administered nutrients and nutrients, a vehicle for use in topical or transdermal nutrient or nutrition administration, nutritional composition and use of an effective amount of one or more phosphate derivatives of one or more electron transfer agents along with other excipients | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
DK1030670T3 (en) | Use of vitamin D derivatives to enhance the action of cytotoxic agents | |
GEP20032967B (en) | Indolyl-3-Glyoxylic Acid Derivatives As an Antitumor Agent and Pharmaceutical Composition | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
WO2001013909A3 (en) | Compositions and methods for treating opiate intolerance | |
GEP20033079B (en) | Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency | |
AU3492100A (en) | Oxadiazole compounds and compositions for delivering active agents | |
AU2084801A (en) | Antiviral medication | |
DK1280558T3 (en) | Semi-solid administration vehicle and pharmaceutical compositions | |
AU2002215982A1 (en) | Topical treatment of mastalgia with arometese inhibitors such as androstendione | |
CA2417935A1 (en) | Anti-inflammatory medicament | |
KR960704561A (en) | Composition for prevention and treatment of virally induced tumor | |
KR920019350A (en) | Pharmaceutical Compositions for Autoimmune Disease Therapy | |
TWI256309B (en) | New formulation of mirtazapine | |
WO2001064251A3 (en) | Combination chemotherapy | |
TW200503709A (en) | Itching treating agent containing piperidine derivative as active ingredient | |
CA2361081A1 (en) | Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis | |
GEP20043231B (en) | Resorcinol Composition | |
AU2337900A (en) | Preparation for warts |